Abstract | RATIONALE: OBJECTIVES: This study aimed to investigate the impact of α7 nAChR pharmacological modulation on mecamylamine-precipitated nicotine withdrawal behaviors in mice by using positive allosteric modulators (PAMs). METHODS: The effect of the orthosteric α7 nAChR full agonist PNU282987 (1, 3, 9 mg/kg, s.c.), type I α7 PAM NS1738 (1 and 10 mg/kg; i.p.) and the type II α7 PAM PNU120596 (3 and 9 mg/kg, i.p.) on anxiety-like behavior, somatic signs, and hyperalgesia was measured in mice undergoing mecamylamine-precipitated nicotine withdrawal. Mice were infused with 24 mg/kg/day nicotine or saline for 14 days using s.c. osmotic minipumps. Nicotine withdrawal signs were precipitated upon administration of the non-selective nAChR antagonist mecamylamine (3.5 mg/kg, i.p.). RESULTS: CONCLUSIONS: Taken together, our results suggest that modulation of the α7 nAChR can play important roles in mecamylamine-precipitated nicotine withdrawal behaviors in mice. In addition, the effects of PAMs in this study suggest that endogenous acetylcholine/ choline tone is sufficient to attenuate some aspects of precipitated nicotine withdrawal. These findings highlight a beneficial effect of using α7 nAChR PAMs in some aspects of precipitated nicotine withdrawal.
|
Authors | Asti Jackson, Roger L Papke, M Imad Damaj |
Journal | Psychopharmacology
(Psychopharmacology (Berl))
Vol. 235
Issue 7
Pg. 1897-1905
(07 2018)
ISSN: 1432-2072 [Electronic] Germany |
PMID | 29549391
(Publication Type: Journal Article)
|
Chemical References |
- Benzamides
- Bridged Bicyclo Compounds
- Nicotinic Agonists
- Nicotinic Antagonists
- PNU-282987
- alpha7 Nicotinic Acetylcholine Receptor
- Mecamylamine
- Nicotine
|
Topics |
- Animals
- Benzamides
(administration & dosage)
- Bridged Bicyclo Compounds
(administration & dosage)
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Infusion Pumps
- Male
- Mecamylamine
(administration & dosage)
- Mice
- Mice, Inbred ICR
- Nicotine
(administration & dosage, adverse effects)
- Nicotinic Agonists
(administration & dosage)
- Nicotinic Antagonists
(administration & dosage)
- Substance Withdrawal Syndrome
(etiology, physiopathology, psychology)
- alpha7 Nicotinic Acetylcholine Receptor
(agonists, antagonists & inhibitors, physiology)
|